Skip to content

End-of-life distress: all studies

Page 21 of 40: studies 201 to 210 of 391, newest first. Back to the end-of-life distress overview

Research

Persistent Altered States: Psychological Treatment of Psychedelic Adverse Effects

Tidsskrift for Norsk psykologforening December 1, 2025 Bjørn Holmøy, Kristoffer Andreas Aamodt Andersen 3 citations

Interest and use of psychedelic substances is on the rise in the general population. Research has mainly focused on therapeutic applications in formal treatment settings, and little is known about persistent negative effects in naturalistic use. The aim of this paper is to present a clinically relevant overview of the phenomenology and symptoms of enduring mental health problems after...

DOI: 10.52734/hgsn7664 (opens in new tab) Full text (opens in new tab) Feeling Existentialism Context archaeology Adverse effect +6

Psykologisk behandling av vedvarende vansker etter bruk av psykedelika

Tidsskrift for Norsk psykologforening December 1, 2025 Bjørn Holmøy, Kristoffer Andreas Aamodt Andersen 1 citation

Interessen for og bruken av psykedeliske stoffer vokser i befolkningen. Forskning har primært fokusert på terapeutiske anvendelser i formelle behandlingssettinger, og det er lite kunnskap om vedvarende negative effekter ved naturalistisk bruk. Målet med artikkelen er å gi en klinisk relevant oversikt over fenomenologi og symptombilde på langvarige psykiske plager etter bruk av psykedelika. Tre...

DOI: 10.52734/qaow7353 (opens in new tab) Full text (opens in new tab) Clinical practice Public health Subchondral bone

The Role of Psilocybin in End-of-Life Care: Evidence, Mechanisms, and Guidelines

Oncology Rehabilitation in Practice November 1, 2025 Mackenzie Unsworth, Mary Lou Galantino, Robert Sandoval

This article aims to provide a brief overview of the evidence and mechanisms for psilocybin use in EOL care. Additionally, this article will provide guidelines for clinicians to assess patient use and integrate psilocybin into their clinical practice with respect to its current legal status.

Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy for patients with advanced cancer: protocol for a multi-method feasibility trial

Pilot and Feasibility Studies October 28, 2025 Candice Richardson, Cindy Chan, Emily Macgregor et al. 1 citation

BACKGROUND: Individuals with advanced cancer often experience high levels of distress for which there are few standardized treatment approaches. Our multidisciplinary team has combined existing evidence-based approaches into Psilocybin-assisted Existential, Attachment, and RelationaL (PEARL) therapy. PEARL therapy combines elements from psilocybin-assisted psychotherapy, including preparatory...

Alucinógenos como terapia complementar no manejo da depressão: uma revisão integrativa

Brazilian Journal of Implantology and Health Sciences October 10, 2025 Pedro M. P. Raposo, Lucas Almeida Gonçalves, Ana Laura de Araújo Caetano et al.

A depressão é um transtorno de grande impacto clínico e social, frequentemente resistente ao tratamento convencional, o que motiva a busca por estratégias terapêuticas complementares. Psicodélicos como a psilocibina e o MDMA têm se destacado por induzir respostas rápidas e duradouras em sintomas depressivos. Esta revisão integrativa analisou 14 estudos publicados entre 2015 e 2024, selecionados...

DOI: 10.36557/2674-8169.2025v7n10p559-584 (opens in new tab) MDMA Informed consent Palliative care Depression economics +3

Seeking Something Beyond Themselves: A Concept Analysis of Spiritual Awakening Experiences at the End of Life

Nursing Reports October 8, 2025 Manuela Monteiro, Joel Vitorino, Marina de Goés Salvetti et al. 4 citations

Background/Objectives: End-of-life (EoL) experiences are critically important for everyone involved, giving rise to a set of needs that extend far beyond bio-physiological aspects, to encompass the spiritual dimension as the core of human beings. Understanding the processes of spiritual awakening (SA) assists palliative care professionals in enhancing the quality of care provided to individuals...

DOI: 10.3390/nursrep15100358 (opens in new tab) Existentialism Formal concept analysis Spirituality Spiritual care +12

USO TERAPÊUTICO DA PSILOCIBINA: REVISÃO INTEGRATIVA

Revista fisio&terapia October 8, 2025 Maurício Pedro Luciano da Costa, Pedro Bruschi Peiretti, Pedro Vinicius Rodrigues Silveira Silva et al.

A resurgence of scientific and clinical interest in psychedelic-assisted therapies, particularly with Psilocybin, has been observed. This paper presents an integrative literature review aiming to identify the scientific contributions, potential benefits, and limitations of the therapeutic use of psilocybin in mental health. The study followed a rigorous protocol. Searches were conducted in the...

Neurobiological and Therapeutic Potential of Psilocybin in Psychiatric Disorders

Journal of Pharma Insights and Research October 5, 2025 M Loganathan, A Saravanakumar, P. Parthiban et al.

Psilocybin, an indoleamine alkaloid derived from various fungal species, is the subject of renewed, rigorous investigation for its therapeutic potential in psychiatry. This compound, a prodrug for the active metabolite psilocin, functions primarily as a partial agonist at the serotonin 2A (5-HT2A) receptor. Its administration within a structured psychotherapeutic context is associated with...

The Role of Psychedelics in Contemporary Psychological and Interdisciplinary Inquiry.

Journal of Personalized Medicine September 28, 2025 Kerem Kemal Soylemez, Emma Marie de Boo, Aysil Susuzlu et al. 2 citations

Psychedelic compounds are gaining renewed attention across disciplines for their profound psychological and neurobiological effects. Emerging research highlights their efficacy in treating mood disorders, PTSD, and addiction by enhancing neuroplasticity and disrupting maladaptive cognitive patterns. From a psychological standpoint, psychedelics facilitate introspection, emotional processing,...

Attitudes Toward Psychedelic-Assisted Therapies for Cancer-Related Psychosocial Symptoms: A Multi- Stakeholder Analysis

Research Square August 19, 2025 Haley D M Schuman, Julie M Deleemans, Tina Nguyen et al. preprint

Abstract Background Psychedelic-assisted therapy (PAT) is gaining attention as a potential treatment for cancer-related psychosocial symptoms. While growing evidence highlights its promise, little is known about how different stakeholder groups perceive its use in oncology and palliative care. Objectives This study aimed to assess stakeholder-specific perspectives on PAT, including attitudes,...